HealthCare Global Enterprises Ltd - 539787 - Intimation Of Earnings Call To Discuss The Audited Financial Results Of Healthcare Global Enterprises Limited
An Earnings Conference Call has been scheduled on Friday, May 26, 2023, at 9.30 am (IST), to discuss the Audited Financial Results of the Company. HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Intimation Of Board Meeting
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2023 ,inter alia, to consider and approve and take on record the Audited Financial Results (both Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2023. HealthCare Global Enterprises Ltd - 539787 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyHealthCare Global Enterprises Ltd 2CIN NO.L15200KA1998PLC023489 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 113.02 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sunu Manuel Designation: Company Secretary and Compliance Officer EmailId: sunumanuel@hcgel.com Name of the Chief Financial Officer: Srinivasa V Raghvan Designation: Chief Financial Officer EmailId: srini.raghavan@hcgel.com Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. HealthCare Global Enterprises Ltd - 539787 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Securities dematerialised/rematerialised during the quarter ended March 31, 2023 have been furnished to all the Stock Exchanges where all the shares of the Company are lised HealthCare Global Enterprises Ltd - 539787 - Compliances- Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March, 31, 2023
Certificate under Regulation 40 (9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2023 HealthCare Global Enterprises Ltd - 539787 - Compliance Certificate For The Period Ended March 31, 2023
Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 HealthCare Global Enterprises Ltd - 539787 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Securities demateralised and remateralised during the quarter ended March 31, 2023 has been furnished to all the Stock Exchanges where the Companies securities are listed. HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The officials of the Company will be meeting nvestors/Analysts on April 12, 2023 at 9.00 IST HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation regarding resignation of Mr. Abhay Prabhakar Havaldar, Independent Director of the Company, effective from April 02, 2023. HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation regarding re-appointment of Dr. B. S. Ajaikumar as Executive Chairman, w.e.f July 01, 2023 and Mrs. Anjali Ajaikumar Rossi as Executive Director w.e.f. April 01, 2023.